Your browser is not up to date and is not able to run this publication.

TRAUMEEL® PRODUCT MONOGRAPH68

Post-marketing surveillance has demonstrated very good tolerability for Traumeel® formulations (significantly greater than with conventional treatments) with very few adverse effects.[Zenner 1992, 1994, 1997]

Traumeel® is suitable for patients requiring first-line treatment for musculoskeletal injuries and inflammation. It may be particularly suitable for patients who are unable to tolerate conventional anti-inflammatory medication, or for those in whom such treatment is contraindicated.[Arora 2000, Zenner 1992, 1994, 1997]

Investigation of the efficacy and place in therapy of Traumeel® is ongoing, with further randomized controlled trials underway.

Traumeel® is registered as a homeopathic medicinal product for the treatment of musculoskeletal injuries and inflammation.

Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2Traumeel - Product Monograph V2
Powered by Fluidbook